NASDAQ:ALRN - Aileron Therapeutics, Inc.
$1.71
 $-0.02
-1.24%
4:00PM EDT
2019-04-18
Aileron Therapeutics, Inc., incorporated on August 6, 2001, is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and metabolic diseases and inflammation. The Company is advancing its lead oncology program to deliver efficacy and safety in a spectrum of solid and hematological malignancies. Its lead product candidate, ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers. The Company is conducting an ongoing Phase I clinical trial of ALRN-6924 in adult patients with solid tumors or lymphomas expressing non-mutated or wild-type p53 that are refractory to or intolerant of standard therapy. ALRN-6924 may reactivate p53-mediated cell death by targeting both of the natural p53 suppressor proteins, Mouse double minute 2 homolog (MDM2) and MDMX. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ALRN     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 63   203. 85   241. 91  
42 stocks rank:  3. 69 K 1. 44 K 1. 05 K
# analyst opinions:  4. 00   14. 51   13. 97  
mean recommendation:  1. 20   2. 09   2. 01  

quick ratio:  3. 85   5. 27   1. 81  
current ratio:  4. 05   5. 62   2. 25  

target price low:  5. 00   84. 80   115. 21  
target price avg:  2. 86   111. 51   137. 51  
target price high:  1. 80   135. 81   157. 84  
1-yr high:  6. 04   114. 23   138. 78  
last close:  1. 71   87. 66   116. 69  
50-day avg:  1. 78   95. 54   123. 44  
200-day avg:  2. 26   94. 25   121. 11  
1-yr low:  0. 71   72. 78   98. 34  
volume:  30. 60 K 4. 11 M 8. 07 M
50-day avg volume:  282. 18 K 2. 76 M 5. 02 M
200-day avg volume:  166. 26 K 2. 92 M 4. 59 M

1-day return:  -1. 21 % -0. 41 % 0. 07 %
this week return:  1. 79 % -5. 74 % -4. 11 %
12-wk return:  51. 33 % 1. 61 % -0. 05 %
52-wk return:  -71. 52 % 3. 12 % 8. 78 %

enterprise value (EV):  4. 74 M 48. 94 B 114. 64 B
market cap:  45. 68 M 43. 07 B 104. 73 B
EBITDA:  -30. 58 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 15   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -31. 55 M 2. 20 B 4. 20 B

shares outstanding:  26. 71 M 571. 70 M 1. 24 B
shares:  9. 18 M 571. 81 M 1. 23 B
shares short:  467. 58 K 10. 17 M 13. 00 M
shares short prior month:  318. 80 K 9. 54 M 17. 33 M
short ratio:  1. 43   5. 41   3. 28  
short % of float:  5. 74 % 5. 45 % 2. 38 %
total cash/share:  1. 39   11. 14   9. 33  
total cash:  20. 70 M 6. 71 B 7. 15 B
free cash flow:  -19. 69 M 3. 58 B 2. 96 B
operating cash flow:  -27. 93 M 4. 15 B 4. 30 B

book value:  1. 33   12. 78   26. 92  
price/book:  1. 29   3. 06   -1. 74  
gross profits:  -18. 45 M 8. 04 B 34. 86 B
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  51. 43 % --- ---
1-yr mean volatility:  -0. 17 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 14   2. 40   4. 10  
forward EPS:  -0. 60   3. 97   7. 13  
P/E:  -0. 80   13. 63   22. 72  
forward P/E:  -2. 85   -15. 95   13. 99  
PE/G:  0. 03   -1. 65   -1. 32  
growth:  -30. 07 % 127. 12 % 29. 61 %
earnings high:  -0. 24   1. 00   1. 66  
earnings avg:  -0. 37   0. 77   1. 53  
earnings low:  -0. 62   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -46. 39 % -2. 75 % 4. 55 %
return on equity:  -93. 61 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  1. 29   1. 25   0. 93  
sharpe (1yr):  -0. 31   0. 37   0. 70  

held % insiders:  77. 03 % 6. 39 % 3. 38 %
held % institutions:  43. 57 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : ALRN
.        + 0 =             0 :: INITIAL WEIGHT
.   + 41.434 =        41.434 :: spline projection addition
.    x 1.431 =        59.309 :: industry recommendation factor
.    x 2.942 =       174.464 :: symbol recommendation factor
.    x 0.995 =       173.655 :: return on assets factor
.    x 0.991 =       172.029 :: return on equity factor
.    x 2.721 =       468.088 :: current ratio factor
.    x 1.162 =       543.947 :: quick ratio factor
.    x 1.304 =       709.074 :: short ratio factor
.    x 2.013 =      1427.272 :: price-to-book factor
.    x 2.164 =      3088.546 :: P/E weight
.    x 2.209 =      6822.473 :: PE/G factor
.    x 1.409 =      9613.112 :: beta factor
.    x 0.312 =      2996.763 :: sharpe factor
.    x 2.634 =      7893.453 :: target low factor
.    x 1.274 =     10055.668 :: target mean factor
.    x 1.023 =     10286.361 :: target high factor
.     x 1.31 =      13473.98 :: industry 2-weeks return factor
.    x 0.973 =     13109.102 :: overall "drift" factor
.    x 0.486 =      6367.279 :: largest single-day jump factor
.    x 0.065 =       411.589 :: low price factor
.      x 1.0 =       411.522 :: factor hist industry gain for week 16
.   cubeRoot =         7.438 :: reduced to standardize
.   - 30.613 =         0.626 :: add/subtract for performance
.                      0.626 :: FINAL WEIGHT for NASDAQ:ALRN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org